Prioritisation of Structural Variant Calls in Cancer Genomes
Overview
Environmental Health
General Medicine
Authors
Affiliations
Sensitivity of short read DNA-sequencing for gene fusion detection is improving, but is hampered by the significant amount of noise composed of uninteresting or false positive hits in the data. In this paper we describe a tiered prioritisation approach to extract high impact gene fusion events from existing structural variant calls. Using cell line and patient DNA sequence data we improve the annotation and interpretation of structural variant calls to best highlight likely cancer driving fusions. We also considerably improve on the automated visualisation of the high impact structural variants to highlight the effects of the variants on the resulting transcripts. The resulting framework greatly improves on readily detecting clinically actionable structural variants.
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.
Long G, Shklovskaya E, Satgunaseelan L, Mao Y, Pires da Silva I, Perry K Nat Med. 2025; .
PMID: 40016450 DOI: 10.1038/s41591-025-03512-1.
Chen Y, Chen C, Chiang T, Chan M, Hsiao M, Ke H Nucleic Acids Res. 2023; 51(15):7777-7797.
PMID: 37497782 PMC: 10450196. DOI: 10.1093/nar/gkad623.
Ahsan M, Liu Q, Perdomo J, Fang L, Wang K Nat Methods. 2023; 20(8):1143-1158.
PMID: 37386186 PMC: 11208083. DOI: 10.1038/s41592-023-01932-w.
Mafficini A, Simbolo M, Shibata T, Hong S, Pea A, Brosens L Mod Pathol. 2022; 35(12):1929-1943.
PMID: 36056133 PMC: 9708572. DOI: 10.1038/s41379-022-01143-2.
Mattiolo P, Mafficini A, Lawlor R, Marchegiani G, Malleo G, Pea A Virchows Arch. 2022; 481(1):41-47.
PMID: 35359182 PMC: 9226109. DOI: 10.1007/s00428-022-03317-4.